Initial data from Phase 1/2 study of Incyte’s epacadostat + Opdivo to be presented at ASCO; shares ahead 8% premarket

from Stock Market News http://ift.tt/2ruLiDr’s-epacadostat-+-opdivo-to-be-presented-at-asco;-shares-ahead-8-premarket-485947

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s